Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy

Identification of reliable biomarkers to predict efficacy of immune checkpoint inhibitors and to monitor relapse in cancer patients receiving this therapy remains one of the main objectives of cancer immunotherapy research. We found that the pretreatment B cell number in the peripheral blood differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shumin, Liu, Yuqing, Till, Brian, Song, Yongping, Wang, Zibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584071/
https://www.ncbi.nlm.nih.gov/pubmed/33162976
http://dx.doi.org/10.3389/fimmu.2020.563653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584071/
https://www.ncbi.nlm.nih.gov/pubmed/33162976
http://dx.doi.org/10.3389/fimmu.2020.563653

Ejemplares similares